More bad news in fight against persistent HIV reservoirs

July 22, 2014 by Monte Morin, Los Angeles Times
Scanning electron micrograph of HIV-1 budding from cultured lymphocyte. Credit: Goldsmith

July has been a particularly trying month for HIV/AIDS researchers as they mourned the loss of colleagues killed in a militant attack and received new reports of the virus' remarkable tenacity.

This week, a study published in Annals of Internal Medicine found that two HIV patients who were given "new" immune systems in the form of suffered renewed HIV infection after initially testing negative for the disease.

Publication of the study follows news this month that the so-called Mississippi baby recently tested positive for HIV. The child, who was born to an infected mother, was placed on antiretroviral drugs just 30 hours after birth and was believed to have been "functionally cured" of the disease. In reality, she had been infected all along.

In both cases, researchers pointed to the persistence of so-called latent reservoirs of the that remain hidden in human tissues and cannot be detected by blood tests.

"The most sobering lesson was that these cases, along with the Mississippi baby, have raised the possibility that total elimination of every last virus or infected cell to achieve lifelong remission may not be possible," wrote Sharon Lewin, an infectious disease physician and local co-chair of this year's International AIDS Conference in Australia. (Lewin commented in an editorial that accompanied the paper, but did not participate in the study.)

In the latest paper, published Monday, researchers described the cases of two men who were infected with HIV - one who was born to an infected mother and one who was exposed to the virus during sex.

They both suffered from another condition as well: Hodgkin's lymphoma, a cancer of the . Because of this, they were given transplants of immune cell-producing bone marrow.

Researchers had hoped that the introduction of donor immune cells, as well as continued treatment with , would succeed in wiping out the patients' viral reservoirs.

Reservoirs occur when the virus enters the body's CD4 white blood cells - cells that are crucial to the function of the immune system - and hide instead of reproducing. In this resting state, the virus cannot be detected, nor can it be killed by the body's immune system. However, it can later become active and begin mass producing itself, steadily eroding the body's defenses and causing AIDS.

Enthusiasm for treating HIV with bone marrow transplants was generated by the so-called second Berlin patient, who has not tested positive for HIV since 2008, when he received a similar transplant.

Unlike the patients in the latest study however, the Berlin patient received bone marrow from a donor who had an extremely rare gene mutation that conferred resistance to HIV.

Dr. Timothy Henrich, lead study author and infectious disease specialist at Harvard's Brigham and Women's Hospital, wrote that although the two men showed no evidence of the virus after the transplant, that was not the case after antiretroviral drug treatment ended.

Researchers wrote that the antiretroviral therapy, or ART, was continued for a period of years - two in one patient, four in the other - in hopes that it would help kill remaining reservoirs. During that time, the disease dropped to undetectable levels.

To see whether the men had been cured, they were removed from the drug regimen and closely monitored for the reappearance of the virus.

In one patient, the virus returned after 12 weeks; in the other it returned after 32 weeks. Once the virus was detected, the men were placed back on ART.

Although it was disappointing that the HIV returned, researchers noted that it took far longer than it usually does when drug treatment ends - about one to four weeks.

Study authors said that although donor transplants may lead to significant, sustained reductions in the HIV-1 reservoir, the infection persists at levels that cannot be detected by current tests.

"Persistence of these small numbers of residual infected cells seems to be sufficient to rekindle HIV-1 replication," authors wrote.

Explore further: Search for AIDS cure pushes ahead despite setbacks

Related Stories

Search for AIDS cure pushes ahead despite setbacks

July 19, 2014
Scientists on Saturday vowed to press ahead with their quest for a cure for AIDS, despite losing a veteran colleague and suffering a setback in research.

HIV cure hopes dashed for two US cancer patients (Update 2)

December 6, 2013
The latest hopes of curing AIDS were dashed Friday when US researchers said HIV returned in two men who briefly eradicated the virus after bone marrow transplants for cancer.

Bone marrow transplant eliminates signs of HIV infection

July 26, 2012
Two men with longstanding HIV infections no longer have detectable HIV in their blood cells following bone marrow transplants. The virus was easily detected in blood lymphocytes of both men prior to their transplants but ...

'Mississippi Baby' now has detectable HIV, researchers find

July 10, 2014
The child known as the "Mississippi baby"—an infant seemingly cured of HIV that was reported as a case study of a prolonged remission of HIV infection in The New England Journal of Medicine last fall—now has detectable ...

2 stem cell patients stop HIV drugs, no virus seen (Update)

July 3, 2013
Two HIV-positive patients in the United States who underwent bone marrow transplants for cancer have stopped anti-retroviral therapy and still show no detectable sign of the HIV virus, researchers said Wednesday.

AIDS cure: Study sees advance for 'kick and kill' strategy

July 22, 2014
The elusive quest for an HIV cure received a boost at the world AIDS conference Tuesday as scientists said they had forced the virus out of a hiding place where it had lurked after being suppressed by drugs.

Recommended for you

Scientists find where HIV 'hides' to evade detection by the immune system

October 19, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confirmed for the very first time the specific immune memory T-cells where infectious HIV 'hides' in the human ...

National roll-out of PrEP HIV prevention drug would be cost-effective

October 18, 2017
Providing pre-exposure prophylaxis (PrEP) medication to men who have sex with men who are at high risk of HIV infection (equivalent to less than 5% of men who have sex with men at any point in time) in England would be cost-effective, ...

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.